Big Growth, Innovation in Rare Disease Biotech

September 6, 2012

September 6, 2012 | Biotech innovation is thriving at Alexion Pharmaceuticals, a company focused on finding treatments that will transform the lives of patients with ultrarare diseases. The company's method has been a success. Alexion's growth has outpaced high rollers like Apple and Salesforce.com with shares up 600% since the approval of Soliris for a rare cause of anemia. Forbes